13,060 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Purchased by Zions Bancorporation N.A.

Zions Bancorporation N.A. bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 13,060 shares of the company's stock, valued at approximately $828,000.

A number of other institutional investors and hedge funds have also bought and sold shares of ACHC. GAMMA Investing LLC increased its holdings in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after buying an additional 241 shares during the period. Blue Trust Inc. boosted its stake in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company's stock valued at $36,000 after purchasing an additional 248 shares in the last quarter. Commonwealth Equity Services LLC boosted its stake in shares of Acadia Healthcare by 3.5% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company's stock valued at $513,000 after purchasing an additional 257 shares in the last quarter. Atria Investments Inc boosted its stake in shares of Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company's stock valued at $434,000 after purchasing an additional 308 shares in the last quarter. Finally, KBC Group NV boosted its stake in shares of Acadia Healthcare by 14.4% in the 3rd quarter. KBC Group NV now owns 2,688 shares of the company's stock valued at $170,000 after purchasing an additional 338 shares in the last quarter.

Acadia Healthcare Stock Down 3.9 %

NASDAQ ACHC traded down $1.54 during trading hours on Friday, reaching $37.82. 1,845,997 shares of the company's stock were exchanged, compared to its average volume of 1,003,388. The company's 50-day moving average is $58.83 and its two-hundred day moving average is $65.92. Acadia Healthcare Company, Inc. has a one year low of $37.78 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 12.90, a price-to-earnings-growth ratio of 1.76 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million during the quarter, compared to analysts' expectations of $819.42 million. During the same period in the prior year, the business earned $0.91 EPS. Acadia Healthcare's revenue for the quarter was up 8.7% compared to the same quarter last year. On average, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ACHC. Barclays reduced their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating on the stock in a research report on Monday, September 30th. StockNews.com upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday. Royal Bank of Canada reiterated an "outperform" rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. KeyCorp began coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Finally, Cantor Fitzgerald restated a "neutral" rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $86.67.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.